MedTrace Logo

Multi-center Observational Study on the Progression of Atherosclerotic Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

NCT04922541 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2021-06-10

No results posted yet for this study

Summary

Multi-center Observational Study on the Progression of Atherosclerotic Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up

Conditions

  • Plaque, Atherosclerotic
  • Programmed Cell Death Protein 1 Inhibitor

Interventions

DRUG

PD-1 inhibitor

dosage form: intravenous injection; frequency: 2-3 weeks; duration: at least 3 months

Sponsors & Collaborators

  • Zhejiang Cancer Hospital

    collaborator OTHER

  • The Affiliated Tumor Hospital of Nantong University, Nantong, Jiangsu Province, China

    collaborator OTHER

  • Sun Yat-sen University

    collaborator OTHER

  • Ningbo Medical Center Lihuili Hospital

    collaborator OTHER_GOV

  • Ningbo No.2 Hospital

    collaborator OTHER

  • Huizhou Municipal Central Hospital

    collaborator OTHER

  • Second Affiliated Hospital, School of Medicine, Zhejiang University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-11-01
Primary Completion
2022-06-30
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04922541 on ClinicalTrials.gov